Revolutionary New Drug Offers 99.9% Protection Against HIV
Despite decades of progress in HIV treatment, more than a million people are newly infected each year, and an effective vaccine remains out of reach. In a breakthrough, the US Food and Drug Administration has approved lenacapavir, a long-acting drug that offers near-complete protection against HIV with just two injections annually.
While HIV prevention drugs, known as pre-exposure prophylaxis (PrEP), have existed for over a decade, their global impact has been limited due to the need for daily pill intake, a routine many struggle to follow consistently.
"This is a historic day in the decades-long fight against HIV. Yeztugo is one of the most important scientific breakthroughs of our time and offers a very real opportunity to help end the HIV epidemic," said Daniel O'Day, Chairman and Chief Executive Officer of Gilead Sciences. "This is a medicine that only needs to be given twice a year and has shown remarkable outcomes in clinical studies, which means it could transform HIV prevention. Gilead scientists have made it their life's work to end HIV, and now, with the FDA approval of Yeztugo and in collaboration with our many partners, we can help to make that goal a reality."
In 2024, Science hailed lenacapavir as its "Breakthrough of the Year".
Lenacapavir, marketed under the brand name Yeztugo, has been shown to reduce the risk of HIV transmission by more than 99.9 percent in adults and adolescents making it functionally akin to a powerful vaccine.
The company conducted two large clinical trials. The first, involving more than 2,000 women in sub-Saharan Africa, resulted in a 100 percent reduction in infections and demonstrated superiority over the daily oral pill Truvada.
In the second trial, involving over 2,000 men and gender-diverse individuals, only two infections were recorded - a 99.9 percent prevention rate, again surpassing Truvada.
Reported side effects included injection site reactions, headache, and nausea.
Results from both trials were published in The New England Journal of Medicine, and the journal Science named lenacapavir its 2024 "Breakthrough of the Year."
Pricing Raises Concerns Over Accessibility
Despite the impressive results, optimism may be tempered by the drug's expected high cost.
An earlier long-acting HIV prevention shot -- cabotegravir, which is injected every two months and was approved by the FDA in 2021 -- costs tens of thousands of dollars per year and has yet to make a major global impact.
While Gilead hasn't disclosed a price for Yeztugo, analysts estimate the US launch cost could reach $25,000 per year. Lenacapavir's current list price for its previously approved use as a treatment for HIV is $39,000 annually, though that is expected to drop when used as a preventive.
Activists are urging Gilead to drastically cut the price to help end the HIV pandemic.
"Even high-income countries will not be able to afford widescale use of lenacapavir at prices above US $20,000 per year," said Andrew Hill of Liverpool University, who led a team of chemists and scientists that found it could be mass-produced and sold for as little as $25 per person per year.
"To charge one thousand times more for a medicine with pandemic-ending potential would be abhorrent," added Winnie Byanyima, under-secretary-general of the United Nations. "We cannot end AIDS with medicines that are so costly."
The approval also comes as President Donald Trump's administration has slashed funding for HIV treatment and prevention programs both abroad and within the United States.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
9 hours ago
- Time of India
Drug offers 99.9% HIV shield, but Indians will have to wait
Mumbai: A new drug promising 99.9% protection against HIV received approval from the US Food & Drug Administration (FDA) a few days ago, but the city's HIV rights activists are sceptical about its practical impact in India. The main concern stems from the new injectable drug lenacapavir's substantial cost of Rs 24 lakh ($28,218) per person for two injections taken six months apart. Also, NACO (National AIDS Control Organisation) has not fully embraced PrEP (pre-exposure prophylaxis) medications, the category to which lenacapavir belongs. "Our govt distributes condoms to break HIV transmission, it provides antiretroviral therapy drugs to prevent parent-to-child transmission of HIV, but it hasn't ever given PrEP to youngsters who are likely to indulge in high-risk behaviour," said health activist Ganesh Acharya. A couple of years ago, NACO made it mandatory for its counselling centres to disburse information on PrEP. He is alarmed because 75% of the 88% diagnosed with HIV in Mumbai between 2023-24 were in the 15-49 age group that is classified as young. PrEP is available for those seeking treatment in the private sector. PrEP, as a method to prevent HIV transmission before a risky exposure, has been around for almost 12 years. It was widely accepted in developed countries, but India's public health machinery never mentioned it until a few years ago. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo "They set up a committee, then a white paper was brought out that served as a backgrounder for guidelines that were drawn up last year. However, there has been no development since," said a doctor with a public hospital. Dr Ishwar Gilada of the People's Health Organisation (India) said PrEP is the lesser evil compared to HIV transmission. "The govt should distribute PrEP to check the spread of the disease, which has only been increasing in recent years. The total number of HIV-positive people in India increased from 2.2 million to 2.5 million in a few years," he added. The problem is more pronounced in Mumbai, he said, where the number of people with sexually transmitted diseases has been rising. "A recent survey in Mumbai among men who have sex with men found that 60% of them were positive for the human papilloma virus. While gonorrhoea and chlamydia vanished 25 years ago, their numbers are shooting up," said Dr Gilada. PrEP would be the solution, according to him. The govt could adopt a three-tier payment system for PrEP: Charge full cost from those who can afford it, subsidy for some, and free for those who cannot afford medications. Despite efforts, NACO officials were not available for comment. PrEP is not the only HIV-related policy that the govt hasn't acted on. Self-testing HIV kits, for instance, are not allowed in India. "We have self-testing kits for pregnancy, diabetes, and Covid, but policymakers fear about the mental health of people after a positive result in self-testing HIV kits," said Dr Gilada. The same logic is possibly behind the delay with introducing PrEP in the public health system, said a senior doctor, as a section of public health officials fear that giving PrEP would seem like a licence for risky behaviour. However, there is hope that lenacapavir would be available in India sooner rather than later. Bala of Bombay Gay said lenacapavir is a "monumental milestone forward in HIV treatment and prevention," but its pricing makes it inaccessible to Indian patients. "So, we have to wait and see if prices will come down over time," he added. Dr Gilada is positive Indian generic pharma companies licensed by Gilead Sciences can bring lenacapavir injections at below $100 per annum cost and may be rolled out soon. "India can do it," he said. In a statement released a couple of days ago, UNAIDS urged Gilead Lifesciences to drop the price of the new HIV prevention shot.
Time of India
15 hours ago
- Time of India
Pins and needles all over the body? Here's what it means
Often, it has happened that suddenly you feel a sharp sensation in your body, but it is not pain. The sensation can be described as "pins and needles" pinching over the body, and can be uncomfortable, if not painful. Tired of too many ads? go ad free now However, what does it really mean when you experience pins and needles all over your body? Let's dip deeper. What is the pins and needles sensation The medical term for pins and needles is paresthesia. It describes unusual sensations you are otherwise not used to, like tingling, prickling, numbness, or a fuzzy feeling on your skin. Almost all of us have experienced this sensation when our arm or leg 'goes off to sleep' (and you are unable to move it) after sitting or lying in one position for too long. This happens because pressure on nerves or blood vessels temporarily blocks signals between your brain and body. When the pressure is suddenly released, the nerves suddenly 'wake up' from their "slumber", and send signals rapidly, causing that familiar tingling or prickling feeling. Usually, this sensation goes away quickly, and is harmless. Common causes While temporary pins and needles are common, and harmless, feeling it all over your body or for a long time may indicate some underlying issues. Here are some common causes: Pressure on Nerves or Blood Vessels Sitting cross-legged, sleeping on your arm, or staying in one position for long can compress nerves or blood flow. This causes temporary pins and needles in the affected area. Once you move and walk a little bit, the feeling usually goes away. Nerve damage Sometimes nerves get irritated or damaged due to injury, or certain medical conditions. This can cause persistent or widespread tingling sensations, that can occur randomly, or in any area of the body. Vitamin Deficiencies Lack of important vitamins like B12 can affect nerve health and cause tingling or numbness in different parts of the body. Tired of too many ads? go ad free now Medical Conditions Several health problems can cause pins and needles all over, including: Diabetes Multiple sclerosis Stroke or ischemic attacks Thyroid Autoimmune conditions like lupus or rheumatoid arthritis Infections such as Lyme disease or HIV Circulatory issues like thoracic outlet syndrome Anxiety or panic attacks Medications and Supplements Certain medicines for cancer, HIV, or seizures can affect nerves and cause tingling. Some supplements, like high doses of vitamin B6 or bodybuilding supplements, can also cause pins and needles. Why does it feel like that Think of your nervous system as a road carrying electrical signals between your brain and body. When nerves are pressed or damaged, this 'traffic' is blocked or disrupted. This causes a loss of normal feeling (numbness) or extra signals (tingling or prickling). When the pressure is removed, nerves become active again, sending rapid signals that feel like pins and needles. This is usually a sign that your nerves are recovering. Should you be concerned Most pins and needles episodes are temporary and harmless. However, you should see a doctor if: The sensation lasts a long time (more than a few minutes) or keeps coming back It spreads to large areas, or affects both sides of your body. You experience weakness, pain, or loss of coordination along with tingling. You have trouble walking, speaking, or controlling your bladder. The sensation started after an injury or accident. How to manage these sensations Here are some simple steps you can take at home: Change your position often. Avoid sitting or lying in one position for too long. Stretch and move regularly. Gentle exercises help improve blood flow and nerve health. Eat a balanced diet. Include foods rich in vitamins, especially B12, to support nerves. Manage stress and anxiety. Relaxation techniques like deep breathing or meditation can reduce symptoms. Avoid tight clothing or accessories. These can compress nerves and blood vessels. Limit alcohol and avoid smoking. Both can damage nerves over time.
Time of India
16 hours ago
- Time of India
Major chocolate recall sweeps U.S stores — here's why your favorite sweet treat might be unsafe
Weaver Nut Company is recalling certain semi-sweet chocolate nonpareils distributed throughout the United States. If you recently purchased semi-sweet chocolate nonpareils from a grocery or retail store, you should double-check the lot number. Major chocolate recall sweeps U.S. stores: The U.S. Food and Drug Administration (FDA) announced in a news release on Wednesday that Weaver Nut Company was recalling its semi-sweet chocolate nonpareils with white or Christmas-colored seeds, with particular lot codes, due to possible unreported milk allergies, as per a report by Newsweek. Although no illnesses have been reported, people who are allergic to milk face a serious risk. The chocolates were sold through supermarkets and retail stores throughout the United States. ALSO READ: McDonald's boycott June 24: Who's behind it, why it's happening, and how long it will last Why is your favourite sweet treat unsafe? According to the FDA's release, the problem was discovered after a wholesale customer complained about differences in product specifications. Live Events The chocolates were labelled as being free of milk, but later laboratory testing revealed that they did contain milk proteins, it added. It further stated that consuming the affected items could result in severe or fatal allergic reactions for people with a milk allergy or severe sensitivity. One of the top nine allergens that the FDA requires to be declared is milk, and improper labelling can be very risky. Why is this recall important? According to the Pennsylvania-based Weaver Nut Company, the recall is a preventative step to protect the public's health. The business is taking all necessary steps to ensure the safety of its products. Which chocolates are affected? Customers are advised to verify product lot codes and return or dispose of any impacted items. Throw away the items or return them to the store for a complete refund. Lot numbers 204206, 204207, 204208, 204209, 204212, 224225 are for Item 47518-Nonpareil, Semi-Sweet Chocolate (Christmas Seeds). Lot numbers 204214-RL, 204214, 204215, 224221, 224222, 224223, 135215, 135216, 135217, 135220, 135221, 145204, 145205-1, 145207-1, and 145210-1 are for Item D2645, Nonpareils, Semi-Sweet Chocolate (White Seeds), as per a report by Newsweek. FAQs What do I do if I have these chocolates? Check the lot number, and if it is recalled, do not eat it. Return it for a refund or dispose of it. Why is the recall so serious? Milk is a major allergen, and consuming it when allergic can result in serious or life-threatening reactions. Economic Times WhatsApp channel )
